“…CYPlAl inducibility and polymorphisms may be an important risk factor for lung and colorectal cancers (Kellermann et al, 1973;Kawajiri and Fujiikuriyama, 1991; Sivaraman et al, 1994) and basal CYPlA1-dependent activities in breast tumours are reported to be negative prognostic indicators for disease-free survival of women with breast cancer (Murray et al, 1991;Pyykko et al, 1991);Vickers et al, (1989) (Jaiswal et al, 1985;Ivy et al, 1988;Pasanen et al, 1988;Vickers et al, 1989;Thomsen et al, 1991Thomsen et al, ,1994. Moreover, several cell lines that express the AhR but are ERnegative are not Ah-responsive and these include MDA-MB-231, Hs578T and doxorubicin-resistant MCF-7 breast cancer cells (Jaiswal et al, 1985;Ivy et al, 1988;Pasanen et al, 1988;Harris et al, 1989;Vickers et al, 1989;Thomsen et al, 1991Thomsen et al, ,1994.…”